Biotechnology Jobs

• UK - Hertfordshire - Ware RD
• On-site
• Lead
• Permanent

Designs and governs modular, end-to-end data-flows for GSK's R&D division, turning scattered systems into reusable, compliance-by-design assets in a machine-readable format. Involves translating business needs into technical data requirements, policy-as-code, metadata ecosystems and agentic solutions, with coaching and peer review across matrix teams.

Azure · GCP

• London
• Hybrid · 2–3 days in office
• €81,000 – €135,000 pa
• Mid-level
• Contract

Owns defined planning process areas within GSK's ERP Evolution Programme, ensuring the global S/4 Planning template integrates with OMP, APO and other planning tools across Rx and Vx supply chains. Leads design, configuration input, documentation, testing, data migration and business readiness for UAT, cutover and post-go-live support, working with SAP functional experts, GPO, PLM, Quality and site teams.

SAP ECC · S/4HANA · OMP +2

• Oxford
• Hybrid
• Mid-level
• Permanent

Builds the data layer for an autonomous lab platform, ingesting high-frequency video, sensor telemetry and robot state across an edge-to-cloud stack using MQTT, Kafka and streaming APIs. Turns raw streams into structured database transactions and a traceable knowledge graph, and shapes data into model-ready formats for vision-language-action and world models alongside AI and robotics researchers.

MQTT · Kafka · HLS

• Waltham, United States
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset, acting as the senior clinical voice on the Medicine Development Team core quad. Leads governance and investment discussions, Health Authority interactions and evidence-generation strategy, while directing Senior Scientists who handle study-level delivery. Hybrid role with at least two days per week on-site.

AI-enabled Insights · Data Platforms

• Stevenage
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset, acting as the senior clinical voice on the Medicine Development Team core quad. Leads governance and health authority interactions while directing Senior Scientists who handle study-level delivery, and mentors clinical development talent.

AI

• Zug, Switzerland
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset, acting as the senior clinical authority on the Medicine Development Team core quad. Leads governance and investment discussions, Health Authority interactions and evidence-generation strategy, while mentoring clinical development talent and applying AI-enabled analytics to speed decision-making.

AI · Advanced Analytics

• London
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Owns the clinical strategy, scientific narrative and benefit-risk framework for a genitourinary oncology asset, acting as the senior clinical authority within the Medicine Development Team. Leads governance and investment discussions, health authority interactions and evidence-generation strategy, while mentoring clinical development talent and applying AI-enabled analytics to speed decision-making.

AI

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Owns the clinical strategy, scientific narrative and benefit-risk framework for genitourinary cancer assets, acting as the senior clinical authority on the Medicine Development Team core quad. Sets asset-level evidence-generation and governance direction while Senior Scientists handle study-level delivery, and represents Clinical Development in health authority and external engagements. Hybrid role with at least two on-site days per week.

AI · Advanced Analytics

• Durham
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, regulatory periodic reports, and benefit-risk assessments while collaborating with cross-functional teams including Clinical Operations, Regulatory, and Biostatistics. Involves presenting complex safety issues to senior governance committees and contributing to global regulatory submissions.

ICH · GVP · CIOMS

• Greater Poland
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, benefit-risk assessment, regulatory periodic reports and RMPs, working within a global cross-functional matrix alongside Clinical Operations, Regulatory and Biostatistics. Distinct for its strong focus on pharmacovigilance governance, safety strategy and scientific writing.

ICH · GVP · CIOMS

• London
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, periodic regulatory reports, RMPs and benefit-risk assessments within a global cross-functional matrix, presenting complex safety issues to senior governance committees. Distinct for its blend of pharmacovigilance strategy, regulatory writing and matrix leadership.

ICH · GVP · CIOMS

• Belgium-Wavre
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, benefit-risk assessment, regulatory periodic reports and RMPs, and contributes to safety strategy within a global cross-functional matrix. Involves presenting complex safety issues to senior governance committees and mentoring matrix colleagues.

ICH · GVP · CIOMS

• Stevenage
• Hybrid
• £119,250 – £198,750 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late pre-candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work across small molecules, biologics and antibody drug conjugates, applying AI/ML and quantitative systems pharmacology methods. Presents and defends modelling outcomes to governance boards and regulators, and contributes to protocols, analysis plans and submissions.

NONMEM · R

• Waltham, United States
• Hybrid
• £188,100 – £313,500 pa
• Director

Leads model-informed drug development for oncology programs, defining and executing model-based strategies from late discovery through lifecycle management. Conducts population PK, exposure-response, simulation-based trial design and dose selection, applying AI/ML, quantitative systems pharmacology and model-based meta-analysis. Presents to governance boards and regulators and works across matrix teams on small molecules, biologics and antibody drug conjugates.

NONMEM · R

• London
• Hybrid
• £119,250 – £198,750 pa
• Director

Leads model-informed drug development for oncology programmes, defining and executing model-based strategies from late candidate selection through life cycle management. Conducts population PK, exposure-response and simulation-based trial design work, applying AI/ML and quantitative systems pharmacology methods, and defends results to governance boards and regulators. Sits within Oncology Translational Medicine's Clinical Pharmacology Modelling and Simulation group, working across small molecules, biologics and antibody drug conjugates.

NONMEM · R